• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Apexigen Announces Phase 2 Data Evaluating Sotigalimab

    GLOBENEWSWIRE

    Apexigen Announces New Phase 2 Data Evaluating Sotigalimab at ASCO

    GLOBENEWSWIRE

    Apexigen Presents New Data from a Ph 2 Trial its CD40 Antibody, Sotigalimab

    GLOBENEWSWIRE

    Apexigen Announces New Data from PII Trial Evaluating its CD40 Antibody

    PRESS RELEASE

    Apexigen Announces Nature Medicine and ASCO Presentation on PII PRINCE Trial

    GLOBENEWSWIRE

    Apexigen Shows New Data from PII Trial on Sotigalimab + Pembrolizumab in MM

    GLOBENEWSWIRE

    Apexigen Announces New Phase 2 Data on Sotigalimab at SITC 2021

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.